Related references
Note: Only part of the references are listed.Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy
Robin Erken et al.
ANNALS OF HEPATOLOGY (2021)
Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load
Marie-Anne Meier et al.
JOURNAL OF HEPATOLOGY (2021)
Understanding HBcrAg components improves the interpretation of clinical HBcrAg assay results
Xupeng Hong et al.
JOURNAL OF HEPATOLOGY (2021)
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
Lung-Yi Mak et al.
HEPATOLOGY (2021)
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)
Seng Gee Lim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Characterization of Hepatitis B Precore/Core-Related Antigens
Xupeng Hong et al.
JOURNAL OF VIROLOGY (2021)
Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey et al.
HEPATOLOGY (2020)
Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
Akihiro Matsumoto et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Relationship between hepatitis B core-related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues
Milan J. Sonneveld et al.
JOURNAL OF VIRAL HEPATITIS (2019)
B Cell Responses: Cell Interaction Dynamics and Decisions
Jason G. Cyster et al.
CELL (2019)
Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study
Di Wu et al.
HEPATOLOGY INTERNATIONAL (2019)
Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy
Ming-Hui Li et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
Yao-Chun Hsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B
Kin Seng Liem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients
Ashish Kumar Vyas et al.
LIVER INTERNATIONAL (2018)
Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients
Xiaowen Wang et al.
GASTROENTEROLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
Bhawna Poonia et al.
SCIENTIFIC REPORTS (2018)
Circulating PD-1(hi)CXCR5(+)CD4(+) T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-alpha therapy
Li Zhang et al.
MOLECULAR IMMUNOLOGY (2018)
Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
Ya-Chih Tien et al.
ARTHRITIS RESEARCH & THERAPY (2018)
A Potent Hepatitis B Surface Antigen Response in Subjects With Inactive Hepatitis B Surface Antigen Carrier Treated With Pegylated-Interferon Alpha
Zhenhuan Cao et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong et al.
LIVER INTERNATIONAL (2017)
Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
En-Qiang Chen et al.
SCIENTIFIC REPORTS (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
Kyu Sik Jung et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Baseline HBsAg and HBcrAg titres allow peginterferon-based precision medicine' in HBeAg-negative chronic hepatitis B patients
M. Martinot-Peignoux et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B
Natthaya Chuaypen et al.
LIVER INTERNATIONAL (2016)
Characteristics of immune memory 10-15 years after primary hepatitis B vaccination
Irena Brunskole Hummel et al.
VACCINE (2016)
Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB
Weiming Yan et al.
ANTIVIRAL THERAPY (2015)
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
B. Maasoumy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal
GUT (2015)
The Expression of TLR-9, CD86, and CD95 Phenotypes in Circulating B Cells of Patients with Chronic Viral Hepatitis B or C before and after Antiviral Therapy
Ping-wei Zhao et al.
MEDIATORS OF INFLAMMATION (2015)
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
Qin Ning et al.
JOURNAL OF HEPATOLOGY (2014)
CD8(+) T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions
Sandra Phillips et al.
JOURNAL OF IMMUNOLOGY (2010)
Adoptive Immune Transfer of Hepatitis B Virus Specific Immunity From Immunized Living Liver Donors to Liver Recipients
Alexandra Schumann et al.
TRANSPLANTATION (2009)
Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
T Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
A Rokuhara et al.
JOURNAL OF VIRAL HEPATITIS (2003)
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
T Kimura et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Share Paper
